VIR
Vir Biotechnology, Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$7.50
$-0.18
(-2.34%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $1.04B | EPS (ttm) | $-3.62 | Current Price | $7.50 |
| Enterprise Value | $637.10M | Forward EPS | $-2.89 | Previous Close | $7.68 |
| P/E Ratio | - | ROA | -25.97% | 52W High | $10.67 |
| Forward P/E | -2.60 | ROE | -49.06% | 52W Low | $4.16 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $6.44 |
| P/S Ratio | 61.89 | Operating Margin | -72267.91% | 200 Day Avg | $5.60 |
| P/B Ratio | 1.31 | Profit Margin | - | Volume | 1.85M |
| EV/EBITDA | -1.25 | Current Ratio | 7.25 | Avg Volume | 1.81M |
| EV/Sales | 37.79 | Quick Ratio | 6.79 | Beta | 1.69 |
| Employees | 408.00 | Debt/Equity | 12.58 | Shares Outstanding | 139.13M |
| Sector | Healthcare | Total Debt | $100.17M | Float Shares | 97.74M |
| Industry | Biotechnology | Total Cash | $506.51M | Short Float | 13.88% |
| Optionable | Yes | Cash/Share | $3.64 | Short Ratio | 6.43 |
| Dividend Yield | - | Book Value/Share | $5.73 | % Held by Insiders | 10.42% |
| Target Price | $16.33 | Revenue (TTM) | $16.86M | % Held by Institutions | 78.49% |